William B. Stilley III - 22 Aug 2022 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Director
Signature
/s/ William B. Stilley, III
Issuer symbol
ADIL
Transactions as of
22 Aug 2022
Net transactions value
$0
Form type
4
Filing time
23 Aug 2022, 19:14:33 UTC
Previous filing
25 Feb 2022
Next filing
03 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADIL Stock Options Award $0 +100,000 $0.000000 100,000 22 Aug 2022 Common Stock 100,000 $0.5550 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options to purchase 100,000 shares of the Company's common stock, vesting 50% after Purnovate, Inc. has held a pre-IND meeting with the FDA and the balance when the IND is granted.